Related references
Note: Only part of the references are listed.A systematic review of experimental evidence for antiviral effects of ivermectin and an in silico analysis of ivermectin's possible mode of action against SARS-CoV-2
Robert T. Kinobe et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2021)
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
A. C. Kalil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness
Sabeena Ahmed et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19 A Randomized Clinical Trial
Eduardo Lopez-Medina et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention
Anshika Sharma et al.
VIRUSES-BASEL (2021)
Positive impact of oral hydroxychloroquine and povidone-iodine throat spray for COVID-19 prophylaxis: An open-label randomized trial
Raymond Chee Seong Seet et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture
Khushboo Bafna et al.
CELL REPORTS (2021)
Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2
Mark Dittmar et al.
CELL REPORTS (2021)
Distinct uptake, amplification, and release of SARS-CoV-2 by M1 and M2 alveolar macrophages
Jiadi Lv et al.
CELL DISCOVERY (2021)
Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines
Andrew Bryant et al.
AMERICAN JOURNAL OF THERAPEUTICS (2021)
Drug repurposing screens identify chemical entities for the development of COVID-19 interventions
Malina A. Bakowski et al.
NATURE COMMUNICATIONS (2021)
Comparative Transcriptomic and Molecular Pathway Analyses of HL-CZ Human Pro-Monocytic Cells Expressing SARS-CoV-2 Spike S1, S2, NP, NSP15 and NSP16 Genes
Anshika Sharma et al.
MICROORGANISMS (2021)
Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial
Alejandro Krolewiecki et al.
ECLINICALMEDICINE (2021)
The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial
Carlos Chaccour et al.
ECLINICALMEDICINE (2021)
SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via toll-like receptor 4 signaling in murine and human macrophages
Ken Shirato et al.
HELIYON (2021)
The broad spectrum antiviral ivermectin targets the host nuclear transport importin alpha/beta 1 heterodimer
Sundy N. Y. Yang et al.
ANTIVIRAL RESEARCH (2020)
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
Canrong Wu et al.
ACTA PHARMACEUTICA SINICA B (2020)
The COVID-19 Pandemic: Effects on Low- and Middle-Income Countries
Choon-Looi Bong et al.
ANESTHESIA AND ANALGESIA (2020)
M1 But Not M0 Extracellular Vesicles Induce Polarization of RAW264.7 Macrophages Via the TLR4-NFκB Pathway In Vitro
Yulong Shi et al.
INFLAMMATION (2020)
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Jianjun Gao et al.
BIOSCIENCE TRENDS (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
Virological assessment of hospitalized patients with COVID-2019
Roman Woelfel et al.
NATURE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
Leon Caly et al.
ANTIVIRAL RESEARCH (2020)
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
Ka-Tim Choy et al.
ANTIVIRAL RESEARCH (2020)
Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2
Zhiqiang Zheng et al.
EUROSURVEILLANCE (2020)
Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19
Teluguakula Narasaraju et al.
FRONTIERS IN PHARMACOLOGY (2020)
17β-Estradiol Promotes Trained Immunity in Females Against Sepsis via Regulating Nucleus Translocation of RelB
Zhiheng Sun et al.
FRONTIERS IN IMMUNOLOGY (2020)
Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
Yujun Tang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
F. A. Klok et al.
THROMBOSIS RESEARCH (2020)
Thromboembolic disease in COVID-19 patients: A brief narrative review
Samhati Mondal et al.
JOURNAL OF INTENSIVE CARE (2020)
SARS-CoV-2 evades immune detection in alveolar macrophages
Louise Dalskov et al.
EMBO REPORTS (2020)
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Miriam Merad et al.
NATURE REVIEWS IMMUNOLOGY (2020)
How COVID-19 induces cytokine storm with high mortality
Shintaro Hojyo et al.
INFLAMMATION AND REGENERATION (2020)
Doxycycline treatment of high-risk COVID-19-positive patients with comorbid pulmonary disease
Paul A. Yates et al.
THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2020)
Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymerase
Ariane J. Brown et al.
ANTIVIRAL RESEARCH (2019)
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Maria L. Agostini et al.
MBIO (2018)
Porphyromonas gingivalis lipopolysaccharides act exclusively through TLR4 with a resilience between mouse and human
Brice Nativel et al.
SCIENTIFIC REPORTS (2017)
Myeloid-epithelial cross talk coordinates synthesis of the tissue-protective cytokine leukemia inhibitory factor during pneumonia
Katrina E. Traber et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2017)
Drug combination therapy increases successful drug repositioning
Wei Sun et al.
DRUG DISCOVERY TODAY (2016)
Immortalized MH-S cells lack defining features of primary alveolar macrophages and do not support mouse pneumovirus replication
Todd A. Brenner et al.
IMMUNOLOGY LETTERS (2016)
Regulation of macrophage polarization and plasticity by complex activation signals
Tim D. Smith et al.
INTEGRATIVE BIOLOGY (2016)
Evaluation of antiviral activities of Houttuynia cordata Thunb. extract, quercetin, quercetrin and cinanserin on murine coronavirus and dengue virus infection
K. H. Chiow et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2016)
Macrophage polarization in pathology
Antonio Sica et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
When Does 2 Plus 2 Equal 5? A Review of Antimicrobial Synergy Testing
Christopher D. Doern
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
Kylie M. Wagstaff et al.
BIOCHEMICAL JOURNAL (2012)
Doxycycline treatment attenuates acute lung injury in mice infected with virulent influenza H3N2 virus: Involvement of matrix metalloproteinases
H. H. Ng et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2012)
Up-regulation of IL-6 and TNF-α induced by SARS-coronavirus spike protein in murine macrophages via NF-κB pathway
Wei Wang et al.
VIRUS RESEARCH (2007)
Efficient replication of pneumonia virus of mice (PVM) in a mouse macrophage cell line
Kimberly D. Dyer et al.
VIROLOGY JOURNAL (2007)
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J. Vincent et al.
VIROLOGY JOURNAL (2005)
Viral activation of macrophages through TLR-dependent and -independent pathways
L Malmgaard et al.
JOURNAL OF IMMUNOLOGY (2004)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)
Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia
SD Aaron et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
